Verge Genomics

About:

Verge Genomics uses machine learning and human genomics to accelerate drug discovery.

Website: http://www.vergegenomics.com

Twitter/X: VergeGenomics

Top Investors: BlackRock, Eli Lilly, Y Combinator, Alumni Ventures, WuXi AppTec

Description:

Verge Genomics transforms drug discovery with artificial intelligence. Verge was founded by a unique combination of the field's top machine learning experts and seasoned neuroscience drug developers. Together, they share the vision that exponential advances in computational genomics combined with new insights into neuroscience has created a breakthrough opportunity to discover drugs that dramatically improve the lives of patients suffering from neurodegenerative disease.

Total Funding Amount:

$134M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2015-01-01

Contact Email:

hello(AT)vergegenomics.com

Founders:

Alice Zhang, Jason Chen

Number of Employees:

11-50

Last Funding Date:

2023-07-01

IPO Status:

Private

© 2024 MyAiNote.com